{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:06:34Z","timestamp":1791331594497,"version":"4.3.1"},"reference-count":55,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T00:00:00Z","timestamp":1553817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Russian State Assignment","award":["GZ-25\/16"],"award-info":[{"award-number":["GZ-25\/16"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: The lack of effective vaccines against Ebola virus initiates a search for new approaches to overcoming this problem. The aim of the study was to design artificial polyepitope T-cell immunogens\u2014candidate DNA vaccines against Ebola virus and to evaluate their capacity to induce a specific immune response in a laboratory animal model. Method: Design of two artificial polyepitope T-cell immunogens, one of which (EV.CTL) includes cytotoxic and the other (EV.Th)\u2014T-helper epitopes of Ebola virus proteins was carried out using original TEpredict\/PolyCTLDesigner software. Synthesized genes were cloned in pcDNA3.1 plasmid vector. Target gene expression was estimated by synthesis of specific mRNAs and proteins in cells transfected with recombinant plasmids. Immunogenicity of obtained DNA vaccine constructs was evaluated according to their capacity to induce T-cell response in BALB\/c mice using IFN ELISpot and ICS. Results: We show that recombinant plasmids pEV.CTL and pEV.Th encoding artificial antigens provide synthesis of corresponding mRNAs and proteins in transfected cells, as well as induce specific responses both to CD4+ and CD8+ T-lymphocytes in immunized animals. Conclusions: The obtained recombinant plasmids can be regarded as promising DNA vaccine candidates in future studies of their capacity to induce cytotoxic and protective responses against Ebola virus.<\/jats:p>","DOI":"10.3390\/vaccines7020034","type":"journal-article","created":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T13:09:58Z","timestamp":1553864998000},"page":"34","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["In silico Designed Ebola Virus T-Cell Multi-Epitope DNA Vaccine Constructions Are Immunogenic in Mice"],"prefix":"10.3390","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6016-4002","authenticated-orcid":false,"given":"Sergei I.","family":"Bazhan","sequence":"first","affiliation":[{"name":"State Research Center of Virology and Biotechnology \u201cVector\u201d, Koltsovo, 630559 Novosibirsk Region, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis V.","family":"Antonets","sequence":"additional","affiliation":[{"name":"State Research Center of Virology and Biotechnology \u201cVector\u201d, Koltsovo, 630559 Novosibirsk Region, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4365-8809","authenticated-orcid":false,"given":"Larisa I.","family":"Karpenko","sequence":"additional","affiliation":[{"name":"State Research Center of Virology and Biotechnology \u201cVector\u201d, Koltsovo, 630559 Novosibirsk Region, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana F.","family":"Oreshkova","sequence":"additional","affiliation":[{"name":"State Research Center of Virology and Biotechnology \u201cVector\u201d, Koltsovo, 630559 Novosibirsk Region, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga N.","family":"Kaplina","sequence":"additional","affiliation":[{"name":"State Research Center of Virology and Biotechnology \u201cVector\u201d, Koltsovo, 630559 Novosibirsk Region, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina V.","family":"Starostina","sequence":"additional","affiliation":[{"name":"State Research Center of Virology and Biotechnology \u201cVector\u201d, Koltsovo, 630559 Novosibirsk Region, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei G.","family":"Dudko","sequence":"additional","affiliation":[{"name":"State Research Center of Virology and Biotechnology \u201cVector\u201d, Koltsovo, 630559 Novosibirsk Region, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia A.","family":"Fedotova","sequence":"additional","affiliation":[{"name":"State Research Center of Virology and Biotechnology \u201cVector\u201d, Koltsovo, 630559 Novosibirsk Region, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Ilyichev","sequence":"additional","affiliation":[{"name":"State Research Center of Virology and Biotechnology \u201cVector\u201d, Koltsovo, 630559 Novosibirsk Region, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,3,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"WHO Ebola Response Team, Agua-Agum, J., Ariyarajah, A., Aylward, B., Blake, I.M., Brennan, R., Cori, A., Donnelly, C.A., Dorigatti, I., and Dye, C. (2015). West African Ebola epidemic after one year\u2014Slowing but not yet under control. N. Engl. J. Med., 372, 584\u2013587.","DOI":"10.1056\/NEJMc1414992"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.tim.2014.04.002","article-title":"Post-exposure therapy of filovirus infections","volume":"22","author":"Wong","year":"2014","journal-title":"Trends Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2217\/imt.13.124","article-title":"An update on the use of antibodies against the filoviruses","volume":"5","author":"Saphire","year":"2013","journal-title":"Immunotherapy"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"L\u00e1zaro-Fr\u00edas, A., G\u00f3mez-Medina, S., S\u00e1nchez-Sampedro, L., Ljungberg, K., Ustav, M., Liljestr\u00f6m, P., Mu\u00f1oz-Fontela, C., Esteban, M., and Garc\u00eda-Arriaza, J. (2018). Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins. J. Virol., 92.","DOI":"10.1128\/JVI.00363-18"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Rahim, M.N., Wee, E.G., He, S., Audet, J., Tierney, K., Moyo, N., Hannoun, Z., Crook, A., Baines, A., and Korber, B. (2019). Complete protection of the BALB\/c and C57BL\/6J mice against Ebola and Marburg virus lethal challenges by pan-filovirus T-cell epigraph vaccine. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007564"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1586\/14760584.2014.885841","article-title":"Ebola virus vaccines: An overview of current approaches","volume":"13","author":"Marzi","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: Final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Camacho","year":"2017","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1080\/21645515.2017.1342021","article-title":"Open-label phase I clinical trial of Ad5-EBOV in Africans in China","volume":"13","author":"Wu","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/21645515.2016.1238535","article-title":"Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I\/II trial in healthy adults in Russia","volume":"13","author":"Dolzhikova","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/mt.2013.61","article-title":"Induction of broad cytotoxic T cells by protective DNA vaccination against Marburg and Ebola","volume":"21","author":"Shedlock","year":"2013","journal-title":"Mol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Krause, P.R., Bryant, P.R., Clark, T., Dempsey, W., Henchal, E., Michael, N.L., Regules, J.A., and Gruber, M.F. (2015). Immunology of protection from Ebola virus infection. Sci. Transl. Med., 7.","DOI":"10.1126\/scitranslmed.aaa8202"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S347","DOI":"10.1086\/520581","article-title":"Epitopes required for antibody-dependent enhancement of Ebola virus infection","volume":"196","author":"Takada","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.11599\/germs.2013.1034","article-title":"DNA vaccines: Roles against diseases","volume":"3","author":"Khan","year":"2013","journal-title":"Germs"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1586\/14760584.7.2.175","article-title":"Current progress of DNA vaccine studies in humans","volume":"7","author":"Lu","year":"2008","journal-title":"Expert Rev. Vaccines"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.4161\/hv.21873","article-title":"A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge","volume":"8","author":"Badger","year":"2012","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Petkov, S., Starodubova, E., Latanova, A., Kilpel\u00e4inen, A., Latyshev, O., Svirskis, S., Wahren, B., Chiodi, F., Gordeychuk, I., and Isaguliants, M. (2018). DNA immunization site determines the level of gene expression and the magnitude, but not the type of the induced immune response. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0197902"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1517\/17425247.2016.1121990","article-title":"Clinical potential of electroporation for gene therapy and DNA vaccine delivery","volume":"13","author":"Lambricht","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_18","unstructured":"Karpenko, L.I., Bazhan, S.I., Eroshkin, A.M., Antonets, D.V., Chikaev, A.N., and Ilyichev, A.A. (2018, November 05). Artificial Epitope-Based Immunogens in HIV-Vaccine Design. Available online: https:\/\/www.intechopen.com\/books\/advances-in-hiv-and-aids-control\/artificial-epitope-based-immunogens-in-hiv-vaccine-design."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"12459","DOI":"10.1038\/s41598-018-31003-6","article-title":"DNA-launched RNA replicon vaccines induce potent anti-Ebolavirus immune responses that can be further improved by a recombinant MVA boost","volume":"8","author":"Zusinaite","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.molimm.2010.01.020","article-title":"Rational design based synthetic polyepitope DNA vaccine for eliciting HIV-specific CD8+ T cell responses","volume":"47","author":"Bazhan","year":"2010","journal-title":"Mol. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/79626","article-title":"Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya","volume":"6","author":"Hanke","year":"2000","journal-title":"Nat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1586\/14760584.2014.861748","article-title":"Novel approaches in polyepitope T-cell vaccine development against HIV-1","volume":"13","author":"Karpenko","year":"2014","journal-title":"Expert Rev. Vaccines"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/sji.12302","article-title":"Epitope-based peptide vaccine design and target site depiction against Ebola viruses: an immunoinformatics study","volume":"82","author":"Khan","year":"2015","journal-title":"Scand. J. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"D405","DOI":"10.1093\/nar\/gku938","article-title":"The immune epitope database (IEDB) 3.0","volume":"43","author":"Vita","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1134\/S0026893310010152","article-title":"TEpredict: software for T-cell epitope prediction","volume":"44","author":"Antonets","year":"2010","journal-title":"Mol. Biol. (Mosk.)"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Antonets, D.V., and Bazhan, S.I. (2013). PolyCTLDesigner: A computational tool for constructing polyepitope T-cell antigens. BMC Res. Notes, 6.","DOI":"10.1186\/1756-0500-6-407"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-1-61779-564-0_15","article-title":"In silico design of functional DNA constructs","volume":"852","author":"Villalobos","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"ref_28","unstructured":"R Development Core Team (2019, March 22). R: A Language and Environment for Statistical Computing. Vienna, Austria: The R Foundation for Statistical Computing. Available online: https:\/\/www.r-project.org\/."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1016\/j.vaccine.2007.02.058","article-title":"Combined virus-like particle-based polyepitope DNA\/protein HIV-1 vaccine design, immunogenicity and toxicity studies","volume":"25","author":"Karpenko","year":"2007","journal-title":"Vaccine"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Reguzova, A., Antonets, D., Karpenko, L., Ilyichev, A., Maksyutov, R., and Bazhan, S. (2015). Design and evaluation of optimized artificial HIV-1 poly-T cell-epitope immunogens. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0116412"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.smim.2015.03.010","article-title":"Viral immune evasion: Lessons in MHC class I antigen presentation","volume":"27","author":"Luteijn","year":"2015","journal-title":"Semin. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.it.2011.08.001","article-title":"DRiPs solidify: Progress in understanding endogenous MHC class I antigen processing","volume":"32","author":"Yewdell","year":"2011","journal-title":"Trends Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: Ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1016\/S0264-410X(01)00233-X","article-title":"Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines","volume":"19","author":"Livingston","year":"2001","journal-title":"Vaccine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1128\/JVI.01505-07","article-title":"Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections","volume":"82","author":"Depla","year":"2008","journal-title":"J. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13073-016-0263-6","article-title":"Designing string-of-beads vaccines with optimal spacers","volume":"8","author":"Schubert","year":"2016","journal-title":"Genome Med."},{"key":"ref_37","first-page":"1","article-title":"Peptide libraries in cellular immune recognition","volume":"243","author":"Uebel","year":"1999","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1097\/QAD.0b013e32832fae88","article-title":"Design of a HIV-1-derived HLA-B07.02-restricted polyepitope construct","volume":"23","author":"Cardinaud","year":"2009","journal-title":"AIDS"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4049\/jimmunol.165.1.20","article-title":"Cutting edge: Introduction of an endopeptidase cleavage motif into a determinant flanking region of hen egg lysozyme results in enhanced T cell determinant display","volume":"165","author":"Schneider","year":"2000","journal-title":"J. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.4049\/jimmunol.175.4.2252","article-title":"Insertion of the dibasic motif in the flanking region of a cryptic self-determinant leads to activation of the epitope-specific T cells","volume":"175","author":"Zhu","year":"2005","journal-title":"J. Immunol."},{"key":"ref_41","first-page":"779","article-title":"Felix Hoppe-Seyler Lecture 2000. The ubiquitin system and the N-end rule pathway","volume":"381","author":"Varshavsky","year":"2000","journal-title":"Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.4049\/jimmunol.155.4.1818","article-title":"Lysosome-associated membrane protein-1-mediated targeting of the HIV-1 envelope protein to an endosomal\/lysosomal compartment enhances its presentation to MHC class II-restricted T cells","volume":"155","author":"Rowell","year":"1995","journal-title":"J. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"8671","DOI":"10.1074\/jbc.272.13.8671","article-title":"The enhanced immune response to the HIV gp160\/LAMP chimeric gene product targeted to the lysosome membrane protein trafficking pathway","volume":"272","author":"Ruff","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"11671","DOI":"10.1073\/pnas.92.25.11671","article-title":"Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens","volume":"92","author":"Wu","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0021-9258(18)53945-4","article-title":"The motif Tyr-X-X-hydrophobic residue mediates lysosomal membrane targeting of lysosome-associated membrane protein 1","volume":"268","author":"Guarnieri","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0952-7915(98)80124-6","article-title":"HLA supertypes and supermotifs: a functional perspective on HLA polymorphism","volume":"10","author":"Sette","year":"1998","journal-title":"Curr. Opin. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0167-5699(96)80542-1","article-title":"Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs","volume":"17","author":"Sidney","year":"1996","journal-title":"Immunol. Today"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.4049\/jimmunol.171.4.1741","article-title":"Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors","volume":"171","author":"Peters","year":"2003","journal-title":"J. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.194.1.1","article-title":"Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products","volume":"194","author":"Toes","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.4049\/jimmunol.172.11.6649","article-title":"Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules","volume":"172","author":"Bonehill","year":"2004","journal-title":"J. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.4049\/jimmunol.166.8.5250","article-title":"Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4+ and CD8+ T cells","volume":"166","author":"Bonini","year":"2001","journal-title":"J. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.4049\/jimmunol.171.6.2970","article-title":"Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies","volume":"171","author":"Kim","year":"2003","journal-title":"J. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1158\/1078-0432.CCR-05-0699","article-title":"Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy","volume":"11","author":"Fassnacht","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nmeth.1701","article-title":"SignalP 4.0: Discriminating signal peptides from transmembrane regions","volume":"8","author":"Petersen","year":"2011","journal-title":"Nat. Methods"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"10991","DOI":"10.1128\/JVI.75.22.10991-11001.2001","article-title":"Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein","volume":"75","author":"Deml","year":"2001","journal-title":"J. Virol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/7\/2\/34\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:41:38Z","timestamp":1760186498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/7\/2\/34"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,29]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,6]]}},"alternative-id":["vaccines7020034"],"URL":"https:\/\/doi.org\/10.3390\/vaccines7020034","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,29]]}}}